The expanding role of primary care in cancer control

Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., Hamilton, W., Hiom, S., Hunter, D., Lyratzopoulos, G., Macleod, U., Mason, R., Mitchell, G., Neal, R. D., Peake, M., Roland, M., Seifert, B., Sisler, J., Sussman, J., Taplin, S., Vedsted, P., Voruganti, T., Walter, F., Wardle, J., Watson, E., Weller, D., Wender, R., Whelan, J., Whitlock, J., Wilkinson, C., de Wit, N. & Zimmermann, C., Sep-2015, In : Lancet Oncology. 16, 12, p. 1231-1272 42 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard


  • The expanding role of primary care in cancer control

    Final publisher's version, 1.25 MB, PDF document


  • Greg Rubin
  • Annette Berendsen
  • S. Michael Crawford
  • Rachel Dommett
  • Craig Earle
  • Jon Emery
  • Tom Fahey
  • Luigi Grassi
  • Eva Grunfeld
  • Sumit Gupta
  • Willie Hamilton
  • Sara Hiom
  • David Hunter
  • Georgios Lyratzopoulos
  • Una Macleod
  • Robert Mason
  • Geoffrey Mitchell
  • Richard D. Neal
  • Michael Peake
  • Martin Roland
  • Bohumil Seifert
  • Jeff Sisler
  • Jonathan Sussman
  • Stephen Taplin
  • Peter Vedsted
  • Teja Voruganti
  • Fiona Walter
  • Jane Wardle
  • Eila Watson
  • David Weller
  • Richard Wender
  • Jeremy Whelan
  • James Whitlock
  • Clare Wilkinson
  • Niek de Wit
  • Camilla Zimmermann

The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care-its continuous, coordinated, and comprehensive care for individuals and families-are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.

Original languageEnglish
Pages (from-to)1231-1272
Number of pages42
JournalLancet Oncology
Issue number12
Publication statusPublished - Sep-2015


Related Activities
  1. The expanding role of primary care in cancer control: Survivorship Care

    Anna Berendsen (Invited speaker)

    Activity: Talk or presentationProfessional

View all (1) »

ID: 25456115